C
삼익제약
014950KOSDAQ의약품 제조업42.5 / 100
Reference Date: 2026-06-10
Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 30.0% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Samik Pharmaceutical focuses on specialty pharmaceuticals, primarily synthetic drugs, and also operates a CMO business. The company develops products targeting major chronic diseases such as hypertension, diabetes, and hyperlipidemia, with circulatory system drugs accounting for 46.8% of revenue in 2025. It also conducts R&D on natural product-derived new drugs and improved formulations to enhance competitiveness.
Number of Employees
146people
Average Salary
54.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 11.934.0Point
PBR
0.86Industry Average 0.894.0Point
In line with industry avg
ROE
-1.25Industry Average 4.010.0Point
Well below industry avg
Debt Ratio
6.51Industry Average 12.435.0Point
Lower than industry avg (good)
Trend 3.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
0.0 / 4
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 5,930Won52-week high 21,30052-week low 5,930
1-month return0.0Point
1m -29.99% (strong drop)
Volume trend3.0Point
Volume flat
Detailed Disclosure
7 totalPositive 0Neutral 7Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-08
- Neutral주식등의대량보유상황보고서(일반)2026-06-08
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-04
- Neutral주주명부폐쇄기간또는기준일설정2026-05-27
- Neutral주주총회소집결의 (임시주주총회)2026-05-27